Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today we highlight:
- a piece indicating that, “[f]or businesses awaiting a Supreme Court ruling on President Trump’s tariffs, the next three chances for a decision will be Feb. 20, Feb. 24 and Feb. 25”;
- an article suggesting that, “[e]ven as small businesses wait for the U.S. Supreme Court to rule on President Donald Trump’s tariff authority, . . . uncertainty around import duties will continue”;
- an article identifying “a number of trends” related to petitions and decisions by the Patent Trial and Appeal Board and the Federal Circuit and correlating “those trends to concurrent developments in the biopharma industry and legal landscape”; and
- a blog post discussing “whether patent owners are better off facing post-grant challenges at the Patent Trial and Appeal Board . . . or the Central Reexamination Unit . . . at the United States Patent and Trademark Office.”
